clinical trial · NCT00789152
The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)
Organon and Co·phase3·completed·n = 81
Allergic Rhinitisdesloratadinelevocetirizine
brief summary
This was a study to measure the ability of desloratadine and levocetirizine to decrease nasal obstruction in subjects who had study-induced allergic rhinitis. Study participants had allergic rhinitis symptoms induced in a Vienna Challenge Chamber and then received desloratadine or levocetirizine for 8 days. After at least a 10 to 35-day washout period (time when no drug is given), subjects received the opposite treatment for 8 days. Subjects had their total nasal symptom measured.on the 8th day of each treatment period.
started
Dec 1, 2003
primary completion
May 1, 2004
completion
May 1, 2004
last updated
Aug 15, 2024
official title
The Effects of Desloratadine and Levocetirizine on Nasal Obstruction in Subjects With Induced Allergic Rhinitis in the VCC Assessed Clinically and With Nasal Rhinomanometry and Nasal Flowmetry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol